Epirosmanol

Epirosmanol

SCHEMBL3272202

CC(C)c1cc2c(c(O)c1O)[C@@]13CCCC(C)(C)[C@@H]1[C@H](OC3=O)[C@@H]2O

nearest known ligand 0.65

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FDPS P14324 14/20 0.65
▸ PTGES O14684 2/20 0.65
▸ PNLIP P16233 2/20 0.65
▸ MEN1 O00255 2/20 0.65
▸ KMT2A Q03164 2/20 0.65
▸ GGPS1 O95749 6/20 0.47
▸ BCL9 O00512 3/20 0.42
▸ CTNNB1 P35222 3/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ CYP3A4 P08684 2/20 0.42
▸ MAPT P10636 2/20 0.42
▸ HPGD P15428 2/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ ALOX12 P18054 1/20 0.42
▸ GSTO1 P78417 1/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ USP2 O75604 1/20 0.42
▸ TP53 P04637 1/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Epirosmanol SCHEMBL29426648 1.00 FDPS (0.65) FDPSPTGESPNLIPMEN1KMT2A
Rosmanol SCHEMBL13062163 1.00 FDPS (0.65) FDPSPTGESPNLIPMEN1KMT2A
Rosmanol SCHEMBL459610 1.00 FDPS (0.65) FDPSPTGESPNLIPMEN1KMT2A
Rosmanol SCHEMBL28962181 1.00 FDPS (0.65) FDPSPTGESPNLIPMEN1KMT2A
SCHEMBL29385649 0.88 FDPS (0.64) FDPSPTGESPNLIPMEN1KMT2A
SCHEMBL31238108 0.86 FDPS (0.61) FDPSPTGESPNLIPMEN1KMT2A
Rosmanol SCHEMBL28178098 0.86 FDPS (0.50) FDPSPTGESPNLIPMEN1KMT2A
Epiisorosmanol SCHEMBL29511557 0.84 FDPS (0.65) FDPSPTGESPNLIPMEN1KMT2A
Isorosmanol SCHEMBL12574307 0.84 FDPS (0.65) FDPSPTGESPNLIPMEN1KMT2A
Isorosmanol SCHEMBL13294492 0.84 FDPS (0.65) FDPSPTGESPNLIPMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240390504-A1 MULTIFUNCTIONAL CONJUGATES E P O S IASIS RES AND DEVELOPMENT LIMITED (CY) 2024-11-28 — — US claimed
CN-115361876-A Pet food compositions 希尔氏宠物营养品公司 2022-11-18 — — CN claimed
EP-1664262-B1 THE USE OF LABIATAE HERB PREPARATIONS FOR FOAM ENCHANCEMENT OF BEVERAGES KALAMAZOO HOLDINGS INC (US) 2010-06-30 — — EP claimed
WO-2009089326-A2 FOAM-CREATING COMPOSITIONS, FOAMING BEVERAGE COMPOSITIONS, AND METHODS OF PREPARATION THEREOF MOTTS LLP (US) 2009-07-16 — — WO claimed
US-20080286421-A1 FOAM-CREATING COMPOSITIONS, FOAMING BEVERAGE COMPOSITIONS, AND METHODS OF PREPARATION THEREOF MOTTS LLP 2008-11-20 — — US claimed
EP-1664262-A2 THE USE OF LABIATAE HERB PREPARATIONS FOR FOAM ENCHANCEMENT OF BEVERAGES Kalamazoo Holdings, Inc. (US) 2006-06-07 — — EP claimed
US-20050106306-A1 Use of Labiatae herb preparations for foam enhancement of malt beverages KALAMAZOO HOLDINGS, INC. 2005-05-19 — — US claimed
WO-2005028610-A2 THE USE OF LABIATAE HERB PREPARATIONS FOR FOAM ENCHANCEMENT OF BEVERAGES KALAMAZOO HOLDINGS, INC. (US) 2005-03-31 — — WO claimed
US-20240390504-A1 MULTIFUNCTIONAL CONJUGATES E P O S IASIS RES AND DEVELOPMENT LIMITED (CY) 2024-11-28 — — US disclosed
US-11969473-B2 Multifunctional conjugates E.P.O.S IASIS RESEARCH AND DEVELOPMENT LIMITED (CY) 2024-04-30 — — US disclosed
CN-115919709-A Camellia essential oil with repairing and anti-aging effects 上海林清轩生物科技有限公司 2023-04-07 — — CN disclosed
CN-115916430-A Compositions and methods 金属化学有限公司 2023-04-04 — — CN disclosed
US-20230027148-A1 MULTIFUNCTIONAL CONJUGATES E.P.O.S IASIS RESEARCH AND DEVELOPMENT LIMITED (CY) 2023-01-26 — — US disclosed
CN-115361876-A Pet food compositions 希尔氏宠物营养品公司 2022-11-18 — — CN disclosed
EP-1662915-A1 THE USE OF LABIATAE HERB PREPARATIONS FOR EXTENDING THE FLAVOR SHELF LIFE OF MALT BEVERAGES Kalamazoo Holdings, Inc. (US) 2006-06-07 — — EP disclosed
EP-1664262-A2 THE USE OF LABIATAE HERB PREPARATIONS FOR FOAM ENCHANCEMENT OF BEVERAGES Kalamazoo Holdings, Inc. (US) 2006-06-07 — — EP disclosed
US-20050106306-A1 Use of Labiatae herb preparations for foam enhancement of malt beverages KALAMAZOO HOLDINGS, INC. 2005-05-19 — — US disclosed
WO-2005028610-A2 THE USE OF LABIATAE HERB PREPARATIONS FOR FOAM ENCHANCEMENT OF BEVERAGES KALAMAZOO HOLDINGS, INC. (US) 2005-03-31 — — WO disclosed
WO-2005027665-A1 THE USE OF LABIATAE HERB PREPARATIONS FOR EXTENDING THE FLAVOR SHELF LIFE OF MALT BEVERAGES KALAMAZOO HOLDINGS, INC. (US) 2005-03-31 — — WO disclosed
US-20050058745-A1 Use of Labiatae herb preparations for extending the flavor shelf life of malt beverages KALAMAZOO HOLDINGS, INC. 2005-03-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11969473-B2 Multifunctional conjugates MKI67, ACP3, CD44 FDPS 489/4885PTGES 2780/4885PNLIP 1985/4885
US-20230027148-A1 MULTIFUNCTIONAL CONJUGATES MKI67, ACP3, CD44 FDPS 489/4885PTGES 2780/4885PNLIP 1985/4885
US-20240390504-A1 MULTIFUNCTIONAL CONJUGATES MKI67, ACP3, CD44 FDPS 489/4885PTGES 2780/4885PNLIP 1985/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback